Follow-Up of Monotherapy Remitters in the PReDICT Study: Maintenance Treatment Outcomes and Clinical Predictors of Recurrence

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Consulting and Clinical Psychology

• Publication date

  2018-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1037/ccp0000279PMID 29369664PMCID PMC6892631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

  2017cited by this paper
• A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness.

  2016cited by this paper
• Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.

  2016cited by this paper
• Toward a Unified Treatment for Emotional Disorders - Republished Article.

  2016cited by this paper
• RECURRENCE OF MAJOR DEPRESSIVE EPISODES IS STRONGLY DEPENDENT ON THE NUMBER OF PREVIOUS EPISODES

  2014cited by this paper
• Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration.

  2014cited by this paper
• ENHANCING HISPANIC PARTICIPATION IN MENTAL HEALTH CLINICAL RESEARCH: DEVELOPMENT OF A SPANISH‐SPEAKING DEPRESSION RESEARCH SITE

  2014cited by this paper
• Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.

  2014cited by this paper
• Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial.

  2013cited by this paper
• Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.

  2013cited by this paper
• Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis

  2013cited by this paper
• Pretreatment anxiety predicts patterns of change in cognitive behavioral therapy and medications for depression.

  2013cited by this paper
• Recovery and subsequent recurrence in patients with recurrent major depressive disorder.

  2012cited by this paper
• Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial

  2012cited by this paper
• Effects of anxiety on the long-term course of depressive disorders.

  2012cited by this paper
• Psychotherapy Versus Second-Generation Antidepressants in the Treatment of Depression: A Meta-Analysis

  2011cited by this paper
• The mechanisms of tolerance in antidepressant action.

  2011cited by this paper
• Limitations of the Hamilton Anxiety Rating Scale as a primary outcome measure in randomized, controlled trials of treatments for generalized anxiety disorder.

  2010cited by this paper
• Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders

  2010cited by this paper
• Prevalence and predictors of recurrence of major depressive disorder in the adult population

  2009cited by this paper
• Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report

  2009cited by this paper
• National patterns in antidepressant medication treatment.

  2009cited by this paper
• Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression.

  2008cited by this paper
• Psychological treatment of depression: A meta-analytic database of randomized studies

  2008cited by this paper
• The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

  2007cited by this paper
• Risk for recurrence in depression.

  2007cited by this paper
• Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety.

  2006cited by this paper
• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  2006cited by this paper
• Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.

  2006cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

  2006cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial.

  2005cited by this paper
• Cognitive therapy vs medications in the treatment of moderate to severe depression.

  2005cited by this paper
• Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

  2005cited by this paper
• Toward a Unified Treatment for Emotional Disorders

  2004cited by this paper
• Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.

  2004cited by this paper
• Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

  2003cited by this paper
• Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond.

  2003cited by this paper
• Problems in dealing with missing data and informative censoring in clinical trials

  2002cited by this paper
• World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects Revised October 7, 2000

  2001cited by this paper
• A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

  2000cited by this paper
• Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.

  2000cited by this paper
• Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

  2000cited by this paper
• Multiple recurrences of major depressive disorder.

  2000cited by this paper
• Psychological predictors of single and recurrent major depressive episodes.

  1999cited by this paper
• Continuity of depression during the transition to adulthood: a 5-year longitudinal study of young women.

  1999cited by this paper
• Recurrence after recovery from major depressive disorder during 15 years of observational follow-up.

  1999cited by this paper
• A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

  1998cited by this paper
• Experimental avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment.

  1996cited by this paper
• Experiential avoidance and behavioral disorders: A functional dimensional approach to diagnosis and treatment.

  1996cited by this paper
• Preventing hung juries about therapy studies.

  1996cited by this paper
• Residual symptoms after partial remission: an important outcome in depression

  1995cited by this paper
• Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

  1992cited by this paper
• Predictors of relapse into major depressive disorder in a nonclinical population.

  1991cited by this paper
• National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments.

  1989cited by this paper
• The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders.

  1988cited by this paper
• A structured interview guide for the Hamilton Depression Rating Scale.

  1988cited by this paper
• The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

  1987cited by this paper
• Analysis of Survival Data

  1984cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• An inventory for measuring depression.

  1961cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Symptom specific deep brain stimulation for depression

  2025cites this paper
• Assessing in-session rumination during CBT for depression: Replication and further evaluation of an observational measure

  2024cites this paper
• Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence

  2023cites this paper
• Effectiveness of CBT and its modifications for prevention of relapse/recurrence in depression: A systematic review and meta-analysis of randomized controlled trials.

  2022cites this paper
• Does cognitive behavioral therapy reduce the recurrence of depression?

  2022cites this paper
• Initial Severity and Depressive Relapse in Cognitive Behavioral Therapy and Antidepressant Medications: An Individual Patient Data Meta-analysis

  2022cites this paper
• Assessing in-session rumination and its effects on CBT for depression.

  2022cites this paper
• Accountability and Community Participation as Moderates on the Relationship between the Council's Knowledge of the Budget and Supervision of the Management of the Papua Special Autonomy Fund

  2021cites this paper
• Ethical Sensitivity and Moral Considerations of Accounting Students Based on Accounting Ethics Education

  2021cites this paper
• The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE‐II randomized clinical trial

  2020cites this paper
• Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms: A Randomized Clinical Trial.

  2020cites this paper
• Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?

  2020cites this paper
• Recall accuracy for the symptoms of a major depressive episode among clinical trial participants.

  2019cites this paper
• Preventive cognitive therapy versus care as usual in cognitive behavioral therapy responders: A randomized controlled trial.

  2019cites this paper
• Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.

  2019influential citation
• Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.

  2018cites this paper
• Development and validation of a clinical prediction tool to estimate the individual risk of depressive relapse or recurrence in individuals with recurrent depression.

  2018cites this paper
• Cognitive behavioural therapy with optional graded exercise therapy in severely fatigued patients with myotonic dystrophy type 1: a single-blind randomised trial

  2018cites this paper
• Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder

  2018cites this paper